You are here
News
2020
Oct 2020 Cells4Life offers parents a choice of placenta banking services: amniotic membrane or chorionic tissue. Together with umbilical cord tissue, this gives parents access to different types of birth tissues and the unique cell populations that each contains.
Oct 2020 At present, 41% of recruiting cord blood trials are using a specialized cell product derived from cord blood, not just unmanipulated cord blood cells.
Sep 2020 Within the United States, mandatory newborn screening varies dramatically from state to state. Parents that want to screen their baby for all actionable genetic conditions can purchase supplemental newborn screening.
Sep 2020 Three days after a healthy birth, Jack Tilling nearly died. It took his parents and physicians two and a half years of searching to finally learn that Jack's diagnosis is a urea cycle disorder. Jack's diagnosis could have been detected with newborn screening.
Aug 2020 The AABB 2020 Virtual Annual Meeting will be held Oct. 3-5. Session topics include cellular and genetic therapies, sickle cell disease, pediatric care, hematopoietic stem cells, cord blood, platelet transfusion, genotyping, inventory management, biological product collection and utilization – and much, much more.
Aug 2020 In this article we set the record straight about the correct numbers of cumulative or currently recruiting clinical trials that utilize cord blood or cord tissue.
Jul 2020 Exclusive scoop from Dr. Joanne Kurtzberg: The Duke ACT study of Cord Blood for Autism shows significant benefit for children ages 4-7 with non-verbal IQ above 70.
Jul 2020 Simplified highlights for parents: The Duke ACT study of Cord Blood for Autism shows significant benefit for children ages 4-7 with non-verbal IQ above 70.
Jun 2020 Here is a rare story where the father’s stem cells were a perfect match to his daughter and saved the child from a potentially life threatening disorder. The parents' decision to enroll in a Community cord blood stem cell bank covered all the transplant related costs of their child’s medical care.
Jun 2020 Gamida Cell has demonstrated that a stand-alone transplant of expanded cord blood can dramatically shorten engraftment time. We are entering a second generation of cord blood transplants, using products that will hopefully become a routine option for stem cell transplant patients.